ConductScience.org, home

Paper16733337

Olfactory disorders following upper respiratory tract infections.

Welge-Lüssen A and 1 other. Adv Otorhinolaryngol, 2006. Cited by 115 papers, by iCite.

Cite this record

ConductScience Library. Olfactory disorders following upper respiratory tract infections. Papers, record 16733337. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16733337

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Olfactory disorders following upper respiratory tract infections.
PubMed
Journal
Adv Otorhinolaryngol
PubMed
Year
2006
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
115
iCite
Relative citation ratio, by iCite
2.86
iCite
Revised in PubMed
2019-07-10
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Welge-Lüssen AAntje
2Wolfensberger MMarkus

Source PubMed

Download CSV of authors

Topics5

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Olfaction DisordersMajor topic
Respiratory Tract InfectionsMajor topic
Humans
Olfactory Mucosa
Prognosis

Trials2

The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.

TrialTitleThe trial lists it asNamed in the paper's recordSource
NCT05445921Stellate Ganglion Block for COVID-19-Induced Olfactory DysfunctionBackgroundClinicalTrials.gov
NCT06498687Theophylline Nasal Spray for PD-Related Hyposmia and AnosmiaBackgroundClinicalTrials.gov

Download CSV of trials

Cited by86

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 115 citations.

PMIDTitleJournalYearIn PapersSource
41170265Effects of Toki Shakuyaku San on Olfactory Function in a Postmenopausal Mouse Model.Cureus2025https://conductscience.org/library/papers/41170265PubMed
39464360Treatments for Olfactory Dysfunction in COVID-19: A Systematic Review.Int Arch Otorhinolaryngol2024https://conductscience.org/library/papers/39464360PubMed
39160183Association of olfactory and cognitive function test scores with hippocampal and amygdalar grey matter volume: a cross-sectional study.Sci Rep2024https://conductscience.org/library/papers/39160183PubMed
38903957Structures and functions of the normal and injured human olfactory epithelium.Front Neural Circuits2024https://conductscience.org/library/papers/38903957PubMed
38855291Recovery rates and long-term olfactory dysfunction following COVID-19 infection.World J Otorhinolaryngol Head Neck Surg2024https://conductscience.org/library/papers/38855291PubMed
38620197[Olfactory dysfunction in COVID-19, a review of the evidence and implications for pandemic management].Acta Otorrinolaringol Esp2020https://conductscience.org/library/papers/38620197PubMed
38543591SARS-CoV-2 and Other Respiratory Viruses in Human Olfactory Pathophysiology.Microorganisms2024https://conductscience.org/library/papers/38543591PubMed
38212781The burden of persistent symptoms after COVID-19 (long COVID): a meta-analysis of controlled studies in children and adults.Virol J2024https://conductscience.org/library/papers/38212781PubMed
38097777Olfactory immunology: the missing piece in airway and CNS defence.Nat Rev Immunol2024https://conductscience.org/library/papers/38097777PubMed
37894169SARS-CoV-2 and Brain Health: New Challenges in the Era of the Pandemic.Microorganisms2023https://conductscience.org/library/papers/37894169PubMed
37841969Post-viral olfactory loss and parosmia.BMJ Med2023https://conductscience.org/library/papers/37841969PubMed
37568409Heterogeneous Damage to the Olfactory Epithelium in Patients with Post-Viral Olfactory Dysfunction.J Clin Med2023https://conductscience.org/library/papers/37568409PubMed
36517057The incidence and impact of anosmia on daily life after COVID-19 infection: A cross-sectional study in a tertiary center in Saudi Arabia.Saudi Med J2022https://conductscience.org/library/papers/36517057PubMed
36339652Störungen des Riech- und Schmeckvermögens bei COVID-19.Allergo J2022https://conductscience.org/library/papers/36339652PubMed
35772604Nervous system manifestations related to COVID-19 and their possible mechanisms.Brain Res Bull2022https://conductscience.org/library/papers/35772604PubMed
35755859Olfactory and gustatory disorders in COVID-19.Allergo J Int2022https://conductscience.org/library/papers/35755859PubMed
35447981Pathogenesis of Olfactory Disorders in COVID-19.Brain Sci2022https://conductscience.org/library/papers/35447981PubMed
35318656Neuroradiological Basis of COVID-19 Olfactory Dysfunction: A Systematic Review and Meta-Analysis.Laryngoscope2022https://conductscience.org/library/papers/35318656PubMed
35307631Neurological Evaluation of Geriatric Patients Being Treated for COVID-19.Eurasian J Med2022https://conductscience.org/library/papers/35307631PubMed
35249186"Anosmia" the mysterious collateral damage of COVID-19.J Neurovirol2022https://conductscience.org/library/papers/35249186PubMed

See all 86 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/16733337

GET https://conductscience.org/api/papers/v1/16733337/cited_by?page=2